Drawing for LEVOGEL

USPTO serial 85422517

LEVOGEL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HINES, REGINA C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LEVOGEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ARNOLD H. KRUMHOLZ

ARNOLD H. KRUMHOLZ LERNER, DAVID, LITTENBERG, KRUMHOLZ & MENTLIK, LLP600 South Avenue WestWESTFIELD, NJ 07090-1497UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005CONTRACEPTIVE IN THE FORM OF AN INTRAVAGINAL DRUGACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 17, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 17, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 6, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 5, 2016EX3GSOU EXTENSION 3 GRANTED—
Nov 17, 2016EXT3SOU EXTENSION 3 FILED—
Nov 17, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 26, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 25, 2016EX2GSOU EXTENSION 2 GRANTED—
Jul 20, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 15, 2016EXT2SOU EXTENSION 2 FILED—
Jun 15, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 17, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 15, 2015EX1GSOU EXTENSION 1 GRANTED—
Dec 15, 2015EXT1SOU EXTENSION 1 FILED—
Dec 15, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 21, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 7, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2015RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 30, 2014RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 24, 2014RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 17, 2013RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 15, 2013RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 2, 2012RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 2, 2012ALIEASSIGNED TO LIE—
Dec 30, 2011GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 30, 2011GNSLLETTER OF SUSPENSION E-MAILED—
Dec 30, 2011CNSLSUSPENSION LETTER WRITTEN—
Dec 30, 2011DOCKASSIGNED TO EXAMINER—
Sep 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance